EUVIMEDEUVIMED entdecken
Crossref

Clonal Hematopoiesis and Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Retrospective Analysis of the UK Biobank

Klonale Hämatopoese und kardiovaskuläre sowie mikrovaskuläre Outcomes bei Typ-2-Diabetes: retrospektive Analyse der UK Biobank

Yang Gao, Chaowei Zhang iD, Donghui Chen iD, Zhuocheng Shi, Qingbo Shi iD, Yushuo Gu iD, Boyi Shi, Cao Ma, Quan Guo iD, Yunxia Wang, Zhiwen Zhang, Bingchuan Geng iD und 1 weitere

Journal of the American Heart Association · 12.11.2026

DOI: 10.1161/jaha.126.053785 ↗

Auf einen Blick

Bei Erwachsenen mit Typ-2-Diabetes war CHIP mit einem höheren Risiko für mikrovaskuläre Komplikationen und, unter den kardiovaskulären Outcomes, am konsistentesten mit Herzinsuffizienz assoziiert.

Fragestellung

Sind CHIP-assoziierte klonale Hämatopoese und kardiovaskuläre sowie mikrovaskuläre Komplikationen bei Typ-2-Diabetes verbunden?

Methode

Retrospektive Analyse in der UK Biobank; Teilnehmende mit Typ-2-Diabetes, Whole-Exome-Sequenzierung und ohne vorbestehende kardiovaskuläre oder mikrovaskuläre Komplikationen; Fine-Gray-Modelle mit Imputation fehlender Kovariaten.

Ergebnisse

CHIP war mit dem kardiovaskulären Komposit assoziiert (SHR 1,19; 95 %-KI 1,00–1,42), besonders mit Herzinsuffizienz (SHR 1,43; 95 %-KI 1,13–1,81). Auch das mikrovaskuläre Komposit war assoziiert (SHR 1,34; 95 %-KI 1,15–1,56).

Einschränkungen

Die multiomischen Analysen waren explorativ; zusätzliche biologische Befunde erfordern unabhängige Validierung.

Schlussfolgerung der Autor:innen

Bei Erwachsenen mit Typ-2-Diabetes war CHIP mit einem höheren Risiko für mikrovaskuläre Komplikationen und konsistent mit Herzinsuffizienz assoziiert.

Kernaussagen

  • CHIP: assoziiert mit kardiovaskulärem Komposit und Herzinsuffizienz
  • CHIP: assoziiert mit mikrovaskulärem Komposit, CKD und Retinopathie
  • Multiomische Signale waren explorativ und brauchen Validierung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, online erschienen am 12.11.2026. Verfasst von Yang Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fuwai Central China Cardiovascular Hospital, Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Disea…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Clonal Hematopoiesis, Cardiovascular Diseases, Diabetic Angiopathies. Die Arbeit nennt 31 Literaturangaben.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clonal hematopoiesis of indeterminate potential (CHIP) has been associated with cardiovascular disease, but its associations across cardiovascular and microvascular complications in type 2 diabetes remain incompletely characterized.

Methods

We retrospectively analyzed 17 893 UK Biobank participants with type 2 diabetes, whole‐exome sequencing, and no prevalent cardiovascular or microvascular complications. CHIP was defined from the curated UK Biobank call set by ≥1 driver variant with a variant allele fraction ≥2%. Associations with incident outcomes were evaluated using Fine–Gray models with multiple imputation for missing covariates. Driver‐gene, clone‐size, proteomic, and metabolomic analyses were exploratory.

Results

CHIP was present in 670 participants (3.7%) over a median follow‐up of 14.6 years. CHIP was associated with the composite cardiovascular outcome (subdistribution hazard ratio [SHR], 1.19 [95% CI, 1.00–1.42]), with heart failure showing the clearest component association (SHR, 1.43 [95% CI, 1.13–1.81]); acute coronary syndrome and stroke were not significantly associated. CHIP was also associated with the composite microvascular outcome (SHR, 1.34 [95% CI, 1.15–1.56]), broad chronic kidney disease (SHR, 1.28 [95% CI, 1.05–1.57]), and retinopathy (SHR, 1.43 [95% CI, 1.15–1.77]) but not neuropathy or strict diabetes‐specific nephropathy. Ten‐year adjusted risk differences were 1.94% and 3.46% for the cardiovascular and microvascular composites, respectively. Among 2919 proteins, ZBP1 (Z‐DNA–binding protein 1) was the only protein retained after false‐discovery‐rate correction; no metabolite module was associated with CHIP after correction, whereas selected lipoprotein and amino acid/lactate modules were associated with cardiovascular outcomes, particularly heart failure.

Conclusions

In adults with type 2 diabetes, CHIP was associated with a higher risk of incident microvascular complications and, among cardiovascular outcomes, most consistently with heart failure. Exploratory multiomic findings, including a protein‐wide ZBP1 signal and selected metabolic associations with cardiovascular outcomes, provided additional biological context but require independent validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Clonal HematopoiesisCardiovascular DiseasesDiabetic AngiopathiesHumansFemaleRetrospective StudiesMaleUnited KingdomMiddle AgedAgedUK BiobankBiological Specimen BanksRisk FactorsProteomicsExome Sequencing

Stichwörter der Autor:innen

clonal hematopoiesisheart failuremicrovascular complicationsproteomicstype 2 diabetes

Autor:innen und Institutionen

  • Fuwai Central China Cardiovascular Hospital, Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases), Central China Fuwai Hospital of Zhengzhou University, Henan Prov…
  • The First Clinical School of Zhengzhou University Zhengzhou China.
  • Zhengzhou Central Hospital Affiliated to Zhengzhou University Zhengzhou China.
  • Henan Provincial Clinical Research Center for Cardiovascular Disease Zhengzhou China.

ORCID-Profile: Chaowei Zhang, Donghui Chen, Qingbo Shi, Yushuo Gu, Quan Guo, Bingchuan Geng, Muwei Li

Zitieren

APA

Gao, Y., Zhang, C., Chen, D., Shi, Z., Shi, Q., Gu, Y., Shi, B., Ma, C., Guo, Q., Wang, Y., Zhang, Z., Geng, B., & Li, M. (2026). Clonal Hematopoiesis and Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Retrospective Analysis of the UK Biobank. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.053785

Vancouver

Gao Y, Zhang C, Chen D, Shi Z, Shi Q, Gu Y, et al. Clonal Hematopoiesis and Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Retrospective Analysis of the UK Biobank. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.053785

BibTeX
@article{Gao2026,
  author = {Gao, Yang and Zhang, Chaowei and Chen, Donghui and Shi, Zhuocheng and Shi, Qingbo and Gu, Yushuo and Shi, Boyi and Ma, Cao and Guo, Quan and Wang, Yunxia and Zhang, Zhiwen and Geng, Bingchuan and Li, Muwei},
  title = {Clonal Hematopoiesis and Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Retrospective Analysis of the UK Biobank},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.126.053785}
}
Kostenlos starten →